Current Challenges and Landmark Advances in Pulmonary and
Critical Care Medicine

WebCAST CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Intended Audience:

This symposium is designed for emergency medicine specialists, emergency medicine fellows, emergency medicine nurses, nurse practitioners (NPs) with EM concentration, physician assistants (PAs) with emergency medicine focus, prehospital care providers, cardiologists and cardiovascular specialists, critical care physicians and intensivists

Registration:

Enrollment for this webcast is complimentary, and clinicians are invited to attend this CME-certified symposium and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent educational grant from The Medicines Company, Inc.

Accreditation Statement for Jointly-Sponsored Programs:

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Faculty Disclosures:

Joseph Varon, MD, FCCP
Grant/Research Support: The Medicines Company
Consultant: The Medicines Company, ESP/PDL Laboratories
Speaker’s Bureau: ESP/PDL Laboratories

Jerrold H. Levy, MD
Grant/Research Support: Alexion
Consultant: Bayer HealthCare, Dyax, Novo Nordisk, and Organon

Paul Vespa, MD
Consultant: ESP/PDL Laboratories
Speaker Bureau: The Medicines Company, ESP/PDL Laboratories
Advisory Committee: The Medicines Company, ESP/PDL Laboratorie

Program Faculty:

Joseph Varon, MD, FCCP
Clinical Professor of Medicine
Professor, Acute and Continuing Care
The University of Texas Health Science Center at Houston
Clinical Professor of Medicine
The University of Texas Medical Branch-Galveston
Professor of Medicine and Surgery,
UAT, UDEM, UPAEP, UABC, UNE – Mexico
St. Luke’s Episcopal Hospital

Jerrold H. Levy, MD
Professor and Deputy Chair for Research
Emory University School of Medicine
Director of Cardiothoracic Anesthesiology
Cardiothoracic Anesthesiology and Critical Care
Emory Healthcare
Atlanta, GA

Paul Vespa, MD
Associate Professor of Neurosurgery and Neurology
David Geffen UCLA School of Medicine
Director of Neurocritical Care
UCLA School of Medicine
Los Angeles, CA

Educational Objectives:

Participants will:

• Learn about the relationship between pressure control and improvement in clinical outcomes
• Review current management strategies for patients with acute, severe hypertension
• Become familiar with emerging research in the area of acute, severe blood pressure elevation

Disclaimer:

Copyright © 2008 by Pharmatecture, LLC. All rights reserved. Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this HealthWRAP reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this HealthWRAP is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this HealthWRAP is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This HealthWRAP is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This HealthWRAP is not intended for use by the layman.

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2008 All rights reserved